In more serious cases they run the risk of splitting open and causing life-threatening haemorrhages, which in the 1970s was one of the most frequent reasons for emergency surgery
Importantly, the cardiovascular risk reduction was not entirely due to weight loss alone, as it occurred even in patients who failed to lose more than 5% of their body weight
Here are some key aspects of GLP-1 agonists: Target appetite reduction Mimic natural GLP-1 Support sustained weight loss Benefit metabolic health Reduce cardiovascular risks These drugs are part of a growing trend to incorporate medication into weight management strategies
One of the biggest problems with the term microdosing, as it pertains to GLP-1s, Levy says, is that its vague, and theres no consensus on what its referring to
The actual future market size will likely be highly impacted by whether GLP-1RAs end up being used as longer-term treatments for individuals and how costs and pricing evolve over time
For patients interested in exploring whether microdosing GLP-1 aligns with their health goals, the first step is a comprehensive consultation with a provider who can assess candidacy and develop a personalized treatment plan